3D laparoscopic prostatectomy: results of multicentre study  

Figures & data

Table 1. Patient characteristics. Patients underwent 3D LRP in four centres in Finland between 2013 and 2018.

No. of patients	496
Age (years), median (range) [Q1–Q3]	64 (43–76) [59–68]
Tumour clinical characteristics
PSA (ng/ml), median (range) [Q1–Q3]	7.9 (0.7–148) [5.5–11.7]
Gleason score (biopsy), % (n)
6	44.6 (221)
7	40.3 (200)
8	10.5 (52)
9	3.4 (17)
10	1.2 (6)
Primary tumour (T), % (n)
T1c	43.2 (214)
T2	39.3 (195)
T3	17.5 (87)

PSA: prostate-specific antigen.

Table 2. Perioperative data. Patients underwent 3D LRP in four centres in Finland between 2013 and 2018.

	Median (min–max) [Q1–Q3]
Operative time, all cases (min)	137 (78–344) [110–170]
Operative time without lymphadenectomy (min)	120 (78–303) [102–145]
Operative time with lymphadenectomy (min)	180 (97–344) [147–190]
Estimated blood loss (ml)	200 (10–1100) [100–300]
	% (n)
Clavien–Dindo at 3 months
Grade I	8.3 (41)
Grade II	4.5 (22)
Grade IIIa	6.9 (34)
Grade IIIb	1.6 (8)
Grade IVa	0.2 (1)
Grade V	0.2 (1)
Release day from hospital (days after surgery)
Day 1	39.9 (198)
Day 2	41.1 (204)
Day 3	10.1 (50)
Total patients discharged from hospital during first 3 postoperative days	91.1 (452)

Table 3. Oncological results. Patients underwent 3D LRP in four centres in Finland between 2013 and 2018.

	% (n)
pT
T2a	8.7 (43)
T2b	1.2 (6)
T2c	59.5 (295)
T3a	19.5 (97)
T3b	10.9 (54)
T4a	0.2 (1)
pG
6	29 (144)
7	55.4 (275)
8	9.1 (45)
9	5.2 (26)
10	1.2 (6)
Surgical margins
All cases
Negative	72.8 (361)
Positive	27.2 (135)
pT2
Negative	80.2 (276)
Positive	19.8 (68)
≥pT3
Negative	55.9 (85)
Positive	44.1 (67)
pN
Negative	88.2 (141)
Positive	11.8 (19)

Table 4. Functional and oncological results after surgery. Patients underwent 3D LRP in four centres in Finland between 2013 and 2018.

	% (n)
Continence
3 months
Dry	36.9 (170)
Single day-time pad	40.2 (185)
Sheath (continent overnight)	22.2 (102)
Sheath (incontinent)	0.4 (2)
12 months
Dry	67.3 (281)
Single day-time pad	20.4 (85)
Sheath (continent overnight)	11.5 (48)
Sheath (incontinent)	0.7 (3)
PSA (ng/ml)
3 months
˂ 0.2	90.2 (441)
≥0.2	9.8 (48)
12 months
˂ 0.2	91.4 (414)
≥0.2	8.6 (39)